126 related articles for article (PubMed ID: 18654593)
21. Molecular evolutionary patterns in breast cancer.
Shackney SE; Silverman JF
Adv Anat Pathol; 2003 Sep; 10(5):278-90. PubMed ID: 12973049
[TBL] [Abstract][Full Text] [Related]
22. Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findings.
El Sharouni MA; Postma EL; van Diest PJ
Virchows Arch; 2017 Dec; 471(6):707-712. PubMed ID: 28779344
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
Demir H; Turna H; Can G; Ilvan S
J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
[TBL] [Abstract][Full Text] [Related]
24. [E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].
Han A; Xiong M; Li Z; Liang Y
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):27-30. PubMed ID: 11866953
[TBL] [Abstract][Full Text] [Related]
25. The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.
Suryadevara A; Paruchuri LP; Banisaeed N; Dunnington G; Rao KA
World J Surg Oncol; 2010 Jun; 8():51. PubMed ID: 20565965
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
[TBL] [Abstract][Full Text] [Related]
27. The Expression of the Zonula Adhaerens Protein PLEKHA7 Is Strongly Decreased in High Grade Ductal and Lobular Breast Carcinomas.
Tille JC; Ho L; Shah J; Seyde O; McKee TA; Citi S
PLoS One; 2015; 10(8):e0135442. PubMed ID: 26270346
[TBL] [Abstract][Full Text] [Related]
28. Pure or mixed-type invasive lobular carcinoma?
Bulut N; Dede DS; Sari E; Altundag K
Hum Pathol; 2008 Jul; 39(7):1121; author reply 1121. PubMed ID: 18570979
[No Abstract] [Full Text] [Related]
29. Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles.
Voglstaetter M; Thomsen AR; Nouvel J; Koch A; Jank P; Navarro EG; Gainey-Schleicher T; Khanduri R; Groß A; Rossner F; Blaue C; Franz CM; Veil M; Puetz G; Hippe A; Dindorf J; Kashef J; Thiele W; Homey B; Greco C; Boucheix C; Baur A; Erbes T; Waller CF; Follo M; Hossein G; Sers C; Sleeman J; Nazarenko I
J Pathol; 2019 Aug; 248(4):421-437. PubMed ID: 30982971
[TBL] [Abstract][Full Text] [Related]
30. Lymphoepithelioma-like carcinoma of the breast. An unusual pattern of infiltrating lobular carcinoma.
Cristina S; Boldorini R; Brustia F; Monga G
Virchows Arch; 2000 Aug; 437(2):198-202. PubMed ID: 10993283
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas.
Aman NA; Doukoure B; Koffi KD; Koui BS; Traore ZC; Kouyate M; Toure I; Effi AB
Asian Pac J Cancer Prev; 2019 Jan; 20(1):73-79. PubMed ID: 30678383
[TBL] [Abstract][Full Text] [Related]
32. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cell marker Bmi-1 expression is associated with basal-like phenotype and poor survival in breast cancer.
Wang Y; Zhe H; Ding Z; Gao P; Zhang N; Li G
World J Surg; 2012 May; 36(5):1189-1194. PubMed ID: 22366984
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
35. c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.
Nakopoulou L; Gakiopoulou H; Keramopoulos A; Giannopoulou I; Athanassiadou P; Mavrommatis J; Davaris PS
Histopathology; 2000 Apr; 36(4):313-25. PubMed ID: 10759945
[TBL] [Abstract][Full Text] [Related]
36. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
[TBL] [Abstract][Full Text] [Related]
37. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.
Turashvili G; McKinney SE; Goktepe O; Leung SC; Huntsman DG; Gelmon KA; Los G; Rejto PA; Aparicio SA
Mod Pathol; 2011 Jan; 24(1):64-81. PubMed ID: 20852590
[TBL] [Abstract][Full Text] [Related]
38. Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer.
Dubois-Marshall S; Thomas JS; Faratian D; Harrison DJ; Katz E
Clin Exp Metastasis; 2011 Dec; 28(8):811-8. PubMed ID: 21789718
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma.
Butler D; Rosa M
Arch Pathol Lab Med; 2013 Nov; 137(11):1688-92. PubMed ID: 24168512
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.
Narendra S; Jenkins SM; Khoor A; Nassar A
Ann Diagn Pathol; 2015 Apr; 19(2):64-9. PubMed ID: 25682191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
